The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide.
暂无分享,去创建一个
P. Bitterman | D. Ingbar | B. Blazar | P. Taylor | D. Vallera | O D Wangensteen | D A Vallera | B R Blazar | D H Ingbar | A Panoskaltsis-Mortari | P A Taylor | T M Yaeger | P B Bitterman | O. Wangensteen | A. Panoskaltsis‐Mortari | T. Yaeger | Peter B. Bitterman | Thomas M. Yaeger
[1] S. Neben,et al. THE EFFECT OF DONOR T LYMPHOCYTES AND TOTAL‐BODY IRRADIATION ON HEMOPOIETIC ENGRAFTMENT AND PULMONARY TOXICITY FOLLOWING EXPERIMENTAL ALLOGENEIC BONE MARROW TRANSPLANTATION , 1992, Transplantation.
[2] T. Schall,et al. Overexpression of RANTES using a recombinant adenovirus vector induces the tissue-directed recruitment of monocytes to the lung. , 1996, Journal of immunology.
[3] V. Ferrans,et al. Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung. , 1984, The Journal of clinical investigation.
[4] A. Panoskaltsis-Mortari,et al. In situ hybridization with digoxigenin-labeled RNA probes: facts and artifacts. , 1995, BioTechniques.
[5] R. Berg. Determination of 3- and 4-hydroxyproline. , 1982, Methods in enzymology.
[6] Mahlon D. Johnson,et al. Expression of Transforming Growth Factor-β1, -β2, and -β3 mRNA and Protein in the Murine Lung , 1991 .
[7] N. Schmitz,et al. Comparison of cyclophosphamide, cytarabine, and etoposide as immunosuppressive agents before allogeneic bone marrow transplantation. , 1988, Blood.
[8] M. Jordana,et al. Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation. , 1994, American journal of respiratory cell and molecular biology.
[9] N. Fausto. Multifunctional roles for transforming growth factor-beta 1. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[10] H. Bachofen,et al. Pressure-volume curves of air- and liquid-filled excised lungs-surface tension in situ. , 1970, Journal of applied physiology.
[11] H. Deeg,et al. Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial. , 1992, International journal of radiation oncology, biology, physics.
[12] J. Overgaard,et al. Radiotherapy-related lung fibrosis enhanced by tamoxifen. , 1996, Journal of the National Cancer Institute.
[13] M. Anscher,et al. Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast Cancer , 1993 .
[14] P. Vassalli,et al. Pneumopathies of the graft-versus-host reaction. Alveolitis associated with an increased level of tumor necrosis factor mRNA and chronic interstitial pneumonitis. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[15] D. Remick,et al. Intratracheal administration of endotoxin and cytokines. IV. The soluble tumor necrosis factor receptor type I inhibits acute inflammation. , 1993, The American journal of pathology.
[16] A. Fine,et al. The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. , 1987, The Journal of biological chemistry.
[17] G. Steel,et al. Lung damage after hemithoracic irradiation: dependence on mouse strain. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[19] K. Flanders,et al. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. , 1991, American journal of respiratory cell and molecular biology.
[20] W. Haschek,et al. Pulmonary fibrosis--a possible mechanism. , 1979, Toxicology and applied pharmacology.
[21] D. Remick,et al. Intratracheal administration of endotoxin and cytokines. VII. The soluble interleukin-1 receptor and the soluble tumor necrosis factor receptor II (p80) inhibit acute inflammation. , 1994, Clinical immunology and immunopathology.
[22] G. Gray,et al. Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts. , 1995, Blood.
[23] G. Berry,et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation. , 1990, The Journal of heart transplantation.
[24] P. Linsley,et al. In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice. , 1994, Blood.
[25] W. Haschek,et al. Long-term morphologic and biochemical features of experimentally induced lung fibrosis in the mouse. , 1982, Laboratory investigation; a journal of technical methods and pathology.
[26] R. Raghow. Role of transforming growth factor-beta in repair and fibrosis. , 1991, Chest.
[27] J. Hansen,et al. Idiopathic Pneumonia Syndrome after Bone Marrow Transplantation , 1993 .
[28] D. Niewoehner,et al. Bleomycin-induced changes in pulmonary microvascular albumin permeability and extravascular albumin space. , 1983, The American review of respiratory disease.
[29] H. Moses,et al. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta , 1987, Journal of Experimental Medicine.
[30] T. Colby,et al. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[31] R. Schwartz. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy , 1992, Cell.
[32] J. Lazo,et al. Early increases in pulmonary mRNA encoding procollagens and transforming growth factor-beta in mice sensitive to cyclophosphamide-induced pulmonary fibrosis. , 1989, The Journal of pharmacology and experimental therapeutics.
[33] M. Sporn,et al. The Transforming Growth Factor-βs , 1991 .
[34] R. Berg. [17] Determination of 3- and 4-hydroxyproline , 1982 .
[35] W. Lehmacher,et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. , 1990, Blood.
[36] J M Simpson,et al. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. , 1988, Journal of clinical pathology.
[37] H. Witschi,et al. Acute respiratory failure induced by bleomycin and hyperoxia: pulmonary edema, cell kinetics, and morphology. , 1987, Toxicology and applied pharmacology.
[38] C. Song,et al. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants. , 1985, Journal of immunology.
[39] Brown,et al. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. , 1994, Blood.
[40] A. Pearson,et al. Radiation effects on mouse incisor teeth following whole-body doses of up to 16 gray. , 1981, International journal of radiation biology and related studies in physics, chemistry, and medicine.
[41] N. Tarbell,et al. Dose-limiting complications from upper half body irradiation in C3H mice. , 1988, International journal of radiation oncology, biology, physics.
[42] J. Crawford,et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. , 1996, Blood.
[43] B. Corrin,et al. Immunohistochemical localization of transforming growth factor‐β1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders , 1994, Histopathology.
[44] H. Reynolds,et al. Cyclophosphamide modulation of bronchoalveolar cellular populations and macrophage oxidative metabolism. Possible mechanisms of pulmonary pharmacotoxicity. , 1986, The American review of respiratory disease.
[45] L. de Leij,et al. Expression of class II major histocompatibility complex antigens on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis. , 1987, Journal of clinical pathology.
[46] C. C. Morse,et al. Pulmonary toxicity of cyclophosphamide: a 1-year study. , 1985, Experimental and molecular pathology.
[47] W. Woods,et al. Cyclophosphamide & total body irradiation versus busulfan & cyclophosphamide: A randomized comparison of 2 conditioning regimens in autologous bone marrow transplantation for acute myeloid leukemia , 1994 .
[48] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[49] A. Rimm,et al. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. , 1986, Annals of internal medicine.
[50] J. Bluestone,et al. Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier. , 1993, Journal of immunology.
[51] M. Sporn,et al. The Transforming Growth Factor‐Betas: Past, Present, and Future , 1990, Annals of the New York Academy of Sciences.
[52] J. Curtis,et al. Requirement of CD4-positive T cells for cellular recruitment to the lungs of mice in response to a particulate intratracheal antigen. , 1991, The Journal of clinical investigation.
[53] A. Sharpe,et al. Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells. , 1996, Journal of immunology.
[54] E. Kovacs,et al. Transforming Growth Factor-β Production by Lung Macrophages and Fibroblasts , 1991 .
[55] M. Anscher,et al. Changes in plasma transforming growth factor beta in response to high-dose chemotherapy for stage II breast cancer: possible implications for the prevention of hepatic veno-occlusive disease and pulmonary drug toxicity. , 1995, Bone marrow transplantation.
[56] L M Wakefield,et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[57] J. Rosenbloom,et al. Cytokine networks in the regulation of inflammation and fibrosis in the lung. , 1990, Chest.
[58] W. Woods,et al. Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia. , 1995, International journal of radiation oncology, biology, physics.
[59] D. Niewoehner,et al. Solute conductance of blood-gas barrier in hamsters exposed to hyperoxia. , 1986, Journal of applied physiology.
[60] M. J. Evans,et al. Type II cell proliferation related to migration of inflammatory cells into the lung. , 1986, Experimental and molecular pathology.